Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community

Back Bay CEO Jonathan Gertler was recently quoted in an article titled, “Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community,” published in Xconomy and syndicated by Pharmacy Choice.The article profiles the company Proxima and highlights the importance of contract research organizations (CROs) in bridging the gap between life science companies and clinical trial services.Specifically, the article reported: Focusing on early stage companies is not novel, but “it’s extremely important,” says Jonathan Gertler, managing partner and CEO of life sciences consultancy Back Bay Life Science Advisors in Boston. “When you are starting to grow an ecosystem—which is clearly being done now in the Houston area—what you want to try to do is provide critical infrastructure.” In discussing how CROs work with early stage companies, Dr. Gertler further noted that, “It can be very hard to work with [early stage] companies. But if you help these companies to reach a cogent business plan and render them fundable, they are going to be very loyal and trust you and that’s an investment that’s worth making.”Read and share the article here on Xconomy.com.